Day v. Sarasota Doctors Hospital, Inc.

District Court, M.D. Florida·Decided December 11, 2020·No. 8:19-cv-01522·Unknown

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION

DAVID DAY,

Plaintiff,

v. Case No. 8:19-cv-1522-T-33TGW

SARASOTA DOCTORS HOSPITAL, INC. d/b/a DOCTORS HOSPITAL OF SARASOTA,

Defendant. ________________________________/ ORDER This matter is before the Court upon consideration of Defendant Sarasota Doctors Hospital, Inc.’s Motion to Exclude Expert Opinion and Testimony of Kevin McCarty (Doc. # 185), filed on November 13, 2020. Plaintiff David Day responded on November 25, 2020. (Doc. # 192). Doctors Hospital replied on December 9, 2020. (Doc. # 195). For the reasons set forth below, the Motion is granted in part and denied in part. I. Background This is a breach of contract and Florida Deceptive Unfair Practices Act (“FDUTPA”) action that arose out of Day’s treatment at Doctors Hospital. (Doc. # 46). Day initiated this suit in state court on November 30, 2017. (Doc. # 1). Following removal to this Court, and two amended complaints, the case proceeded through discovery. (Id.). In the second amended complaint, Day alleges that Doctors Hospital charged unreasonably high fees for his medical treatment because his only form of insurance was personal injury protection insurance (“PIP insurance”). (Doc. # 46 at ¶ 5). According to Day, [PIP insurance] coverage is required of all drivers in Florida [under the Florida No-Fault law]. By statute, hospitals treating patients covered by PIP may charge the insurer and the injured party only a “reasonable amount” for services and supplies rendered. [Fla. Stat. § 627.736(5)(a)]. The charge for such services and supplies “may not exceed the amount the person or institution customarily charges for like services or supplies,” and the “reasonable amount” for such services and supplies is directly related to the “usual and customary charges and payments accepted by the provider” for such services and supplies, as well as “reimbursement levels in the community” and “federal and state medical fee schedules.” Id.

(Doc. # 46 at ¶ 6). Day contends that Doctors Hospital violated the Florida No-Fault law in charging PIP-insured patients – including himself – these allegedly unreasonable rates. (Id. at ¶ 8). Day intends to rely on Kevin McCarty’s expert opinion and testimony at trial. (Doc. # 193). McCarty has worked in the insurance regulatory industry since 1988 and, most notably, served as the Florida Insurance Commissioner from 2003 to 2016. (Id. at ¶ 1-7). McCarty was tasked with “provid[ing] an opinion on the billing practices of Doctors Hospital . . . under various laws and regulations, including the [PIP] statute.” (Id. at ¶ 9). McCarty’s report discusses, in part, the insurance regulatory industry’s understanding of “usual and customary” medical charges under the PIP statute. (Id. at ¶ 13). McCarty concludes that “Doctors Hospital . . . is charging PIP patients and insurers excessive fees for the services provided; they are being charged at unreasonably

high rates far above what Medicare and private patients are paying for identical services.” (Id. at ¶ 9-10). In the Motion, Doctors Hospital seeks to exclude McCarty’s expert opinion and testimony. (Doc. # 185). Day has responded (Doc. # 192), and Doctors Hospital has replied. (Doc. # 195). The Motion is now ripe for review. II. Discussion Federal Rule of Evidence 702, which governs the admission of expert testimony in federal courts, states: A witness who is qualified as an expert by knowledge, skill, experience, training, or education may testify in the form of an opinion or otherwise if: (a) the expert’s scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principles and methods to the facts of the case.

Fed. R. Civ. P. 702. In Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the Supreme Court held that federal district courts must ensure that any and all scientific testimony or evidence admitted is both relevant and reliable. Id. at 589-90. This analysis applies to non-scientific expert testimony as well. Kumho Tire Co. v. Carmichael, 526 U.S. 137, 147-49 (1999). District courts are tasked with this gatekeeping function so “that speculative, unreliable expert testimony does not reach the jury under the mantle of reliability that accompanies the appellation expert testimony.” Rink v. Cheminova, Inc., 400 F.3d 1286, 1291 (11th Cir. 2005) (citation omitted). In the Eleventh Circuit, trial courts must engage in a “rigorous three-part inquiry” in determining the admissibility of expert testimony. Hendrix v. Evenflo Co., 609 F.3d 1183, 1194 (11th Cir. 2010). Specifically, courts must assess whether: (1) the expert is qualified to testify competently regarding the matters he intends to address; (2) the methodology by which the expert reaches his conclusions is sufficiently reliable as determined by the sort of inquiry mandated in Daubert; and (3) the testimony assists the trier of fact, through the application of scientific, technical, or specialized expertise, to understand the evidence or to determine a fact in issue.

Id. (citation omitted). “The party offering the expert has the burden of satisfying each of these three elements by a preponderance of the evidence.” Adams v. Magical Cruise Co., No. 6:15-cv-282-Orl-37TBS, 2016 WL 11577631, at *2 (M.D. Fla. Oct. 21, 2016) (citing Rink, 400 F.3d at 1292). The Court will address each aspect of the three-part inquiry below. A. McCarty’s Qualifications First, the Court must assess whether McCarty is qualified to testify about the matters he intends to address. City of Tuscaloosa v. Harcros Chems., Inc., 158 F.3d 548, 563 (11th Cir. 1998). An expert may be qualified “by knowledge, skill, experience, training, or education.” Fed. R. Civ. Evid. 702. “Determining whether a witness is qualified to testify as an expert ‘requires the trial court to examine the credentials of the proposed expert in light of the subject matter of the proposed testimony.’” Clena Invs., Inc. v. XL Specialty Ins. Co., 280 F.R.D. 653, 661 (S.D. Fla. 2012) (quoting Jack v. Glaxo Wellcome Inc., 239 F. Supp. 2d 1308, 1314 (N.D. Ga. 2002)). “This inquiry is not stringent, and so long as the expert is minimally qualified, objections to the level of the expert’s expertise go to credibility and weight, not admissibility.” Id. (citations omitted). Here, Doctors Hospital does not dispute McCarty’s qualifications. (Doc. # 195 at 1). Indeed, McCarty has extensive experience in the insurance regulatory industry – stemming over twenty-seven years. (Doc. # 193 at ¶ 2). For thirteen of those years, from 2003 to 2016, McCarty served as Florida’s Commissioner of Insurance Regulation, overseeing the regulation of PIP insurance in Florida, among other

things. (Id.).

Free access — add to your briefcase to read the full text and ask questions with AI

Day v. Sarasota Doctors Hospital, Inc., (M.D. Fla. 2020).

Day v. Sarasota Doctors Hospital, Inc. (Day v. Sarasota Doctors Hospital, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

City of Tuscaloosa v. Harcros Chemicals, Inc.
158 F.3d 548 (Eleventh Circuit, 1998)
United States v. Richard Junior Frazier
387 F.3d 1244 (Eleventh Circuit, 2004)
Rink v. Cheminova, Inc.
400 F.3d 1286 (Eleventh Circuit, 2005)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
Hendrix Ex Rel. Gp v. Evenflo Co., Inc.
609 F.3d 1183 (Eleventh Circuit, 2010)
Jack v. Glaxo Wellcome, Inc.
239 F. Supp. 2d 1308 (N.D. Georgia, 2002)
Seamon Ex Rel. Estate of Seamon v. Remington Arms Co.
813 F.3d 983 (Eleventh Circuit, 2016)
Umana-Fowler v. NCL (Bahamas) Ltd.
49 F. Supp. 3d 1120 (S.D. Florida, 2014)
R.W. v. Board of Regents of University System of Georgia
114 F. Supp. 3d 1260 (N.D. Georgia, 2015)
Clena Investments, Inc. v. XL Specialty Insurance
280 F.R.D. 653 (S.D. Florida, 2012)